Spartin / SPG20 antibody

Principal name

Spartin / SPG20 antibody

Alternative names for Spartin / SPG20 antibody

KIAA0610, TAHCCP1, Trans-activated by hepatitis C virus core protein 1, Spastic paraplegia 20 protein

SwissProt ID

Q8N0X7 (Human), Q8R1X6 (Mouse)

Gene ID

23111 (SPG20), 229285 (Spg20)

Available reactivities

Hu (Human), Bov (Bovine), Can (Canine), Eq (Equine), GP (Guinea Pig), Ms (Mouse), Por (Porcine), Rb (Rabbit), Rt (Rat), Ze (Zebrafish)

Available hosts

Rabbit, Goat

Available applications

Western blot / Immunoblot (WB), Paraffin Sections (P), Flow Cytometry (F), Immunocytochemistry/Immunofluorescence (ICC/IF)

Background of Spartin / SPG20 antibody

Kit Component:
- KN316596G1, Spg20 gRNA vector 1 in pCas-Guide vector
- KN316596G2, Spg20 gRNA vector 2 in pCas-Guide vector
- KN316596D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector
CRISPR Manual:
CRISPR/CAS9 Genome Editing Manual

General readings

Milewska,M., et.al., J. Neurochem. 111 (4): 1022-1030 (2009)
Edwards,T.L., et.al., Biochem. J. 423 (1): 31-39 (2009)

Items 1 to 20 of 24 total

per page
Page:
  1. 1
  2. 2

Primary Antibodies

Catalog No. Host Iso. Clone Pres. React. Applications  

Spartin / SPG20 antibody

  Goat Anti-SPG20 / SPARTIN Antibody  
(2ug/ml) staining of HeLa lysate (35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence. Goat Aff - Purified Hu ICC/IF, WB
0.1 mg / €325.00
  OriGene Technologies, Inc.

Spartin / SPG20 antibody

  Rabbit Polyclonal Anti-SPG20 Antibody  
WB Suggested Anti-SPG20 Antibody Titration: 0.2-1 ug/ml; Positive Control: OVCAR-3 cell lysateSPG20 is supported by BioGPS gene expression data to be expressed in OVCAR3 Rabbit IgG Purified Bov, Can, Eq, GP, Hu, Ms, Por, Rb, Rt, Ze WB
50 µg / €325.00
  OriGene Technologies, Inc.

Spartin / SPG20 (C-term) antibody

Western blot analysis of Spartin / SPG20 Antibody (C-term) Cat.-No AP54015PU-N in 293 cell line lysates (35ug/lane).This demonstrates the SPG20 antibody detected the SPG20 protein (arrow). Rabbit Ig Aff - Purified Hu WB
0.4 ml / €370.00
  Acris Antibodies GmbH

Spartin / SPG20 (N-term) antibody

Immunohistochemistry analysis of human brain tissue (Formalin-fixed, Paraffin-embedded) using Spartin / SPG20 antibody
Cat.-No. AP54016PU-N (N-term), followed by peroxidase-conjugated secondary antibody and DAB staining. This data demonstrates the use of this antibody for IHC; clinical relevance has not been evaluated. Rabbit Ig Aff - Purified Hu F, P, WB
0.4 ml / €370.00
  Acris Antibodies GmbH

CRISPR

Catalog No. Species Donor Vector  

SPG20 - human gene knockout kit via CRISPR

SPG20 - human gene knockout kit via CRISPR Human GFP-Puro
1 kit / €1,200.00
  OriGene Technologies, Inc.

SPG20 - human gene knockout kit via CRISPR

SPG20 - human gene knockout kit via CRISPR Human mBFP-Neo
1 kit / €1,290.00
  OriGene Technologies, Inc.

Spg20 - mouse gene knockout kit via CRISPR

Spg20 - mouse gene knockout kit via CRISPR Mouse GFP-Puro
1 kit / €1,200.00
  OriGene Technologies, Inc.

Spg20 - mouse gene knockout kit via CRISPR

Spg20 - mouse gene knockout kit via CRISPR Mouse mBFP-Neo
1 kit / €1,290.00
  OriGene Technologies, Inc.

Spg20 - mouse gene knockout kit via CRISPR

Spg20 - mouse gene knockout kit via CRISPR Mouse Luciferase-Puro
1 kit / €1,290.00
  OriGene Technologies, Inc.

Spg20 - mouse gene knockout kit via CRISPR

Spg20 - mouse gene knockout kit via CRISPR Mouse RFP-BSD
1 kit / €1,290.00
  OriGene Technologies, Inc.

Proteins & Growth Factors

Catalog No. Species Pres. Purity Source  

Spartin / SPG20 (transcript variant 1)

  Recombinant protein of human spastic paraplegia 20 (Troyer syndrome) (SPG20), transcript variant 1  
Spartin / SPG20 Human > 80 %
Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps.
Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining.
HEK293 cells

Regular Price: 20 µg / €680.00

Special Price: 20 µg / €398.00

  OriGene Technologies, Inc.

Spartin / SPG20 (transcript variant 4)

  Purified recombinant protein of Homo sapiens spastic paraplegia 20 (Troyer syndrome) (SPG20), transcript variant 4  
Spartin / SPG20 Human > 80 %
Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps.
Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining.
HEK293 cells
20 µg / €680.00
  OriGene Technologies, Inc.

Spartin / SPG20 (transcript variant 3)

  Purified recombinant protein of Homo sapiens spastic paraplegia 20 (Troyer syndrome) (SPG20), transcript variant 3  
Spartin / SPG20 Human > 80 %
Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps.
Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining.
HEK293 cells
20 µg / €680.00
  OriGene Technologies, Inc.

Spartin / SPG20 (transcript variant 2)

  Purified recombinant protein of Homo sapiens spastic paraplegia 20 (Troyer syndrome) (SPG20), transcript variant 2  
Spartin / SPG20 Human > 80 %
Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps.
Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining.
HEK293 cells
20 µg / €680.00
  OriGene Technologies, Inc.

Human Lenti ORF Particles

Catalog No.    

Lenti ORF particles, SPG20 (mGFP-tagged) - Human spastic paraplegia 20 (Troyer syndrome) (SPG20), transcript variant 1, 200 uL, >10^7 TU/mL

Lenti ORF particles, SPG20 (mGFP-tagged) - Human spastic paraplegia 20 (Troyer syndrome) (SPG20), transcript variant 1, 200 uL, >10^7 TU/mL  
200 µl / €1,050.00
  OriGene Technologies, Inc.

Lenti ORF particles, SPG20 (mGFP-tagged)-Human spastic paraplegia 20 (Troyer syndrome) (SPG20), transcript variant 3, 200 uL, >10^7 TU/mL

Lenti ORF particles, SPG20 (mGFP-tagged)-Human spastic paraplegia 20 (Troyer syndrome) (SPG20), transcript variant 3, 200 uL, >10^7 TU/mL  
200 µl / €1,050.00
  OriGene Technologies, Inc.

Lenti ORF particles, SPG20 (mGFP-tagged)-Human spastic paraplegia 20 (Troyer syndrome) (SPG20), transcript variant 4, 200 uL, >10^7 TU/mL

Lenti ORF particles, SPG20 (mGFP-tagged)-Human spastic paraplegia 20 (Troyer syndrome) (SPG20), transcript variant 4, 200 uL, >10^7 TU/mL  
200 µl / €1,050.00
  OriGene Technologies, Inc.

Lenti ORF particles, SPG20 (Myc-DDK tagged) - Human spastic paraplegia 20 (Troyer syndrome) (SPG20), transcript variant 1 , 200 uL, >10^7 TU/mL

Lenti ORF particles, SPG20 (Myc-DDK tagged) - Human spastic paraplegia 20 (Troyer syndrome) (SPG20), transcript variant 1 , 200 uL, >10^7 TU/mL  
200 µl / €940.00
  OriGene Technologies, Inc.

Lenti ORF particles, SPG20 (Myc-DDK-tagged)-Human spastic paraplegia 20 (Troyer syndrome) (SPG20), transcript variant 3, 200 uL, >10^7 TU/mL

Lenti ORF particles, SPG20 (Myc-DDK-tagged)-Human spastic paraplegia 20 (Troyer syndrome) (SPG20), transcript variant 3, 200 uL, >10^7 TU/mL  
200 µl / €940.00
  OriGene Technologies, Inc.

Lenti ORF particles, SPG20 (Myc-DDK-tagged)-Human spastic paraplegia 20 (Troyer syndrome) (SPG20), transcript variant 4, 200 uL, >10^7 TU/mL

Lenti ORF particles, SPG20 (Myc-DDK-tagged)-Human spastic paraplegia 20 (Troyer syndrome) (SPG20), transcript variant 4, 200 uL, >10^7 TU/mL  
200 µl / €940.00
  OriGene Technologies, Inc.

Items 1 to 20 of 24 total

per page
Page:
  1. 1
  2. 2
  • LinkedIn